Search - tctmd.com

Displaying 181 - 200 of 249

Sort: Relevancy | Date

Presentation TCT 2014

Setting-up a Thriving Clinical Research Program: The Basics and More

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, David A. Cox

September 13, 2014

Presentation TCT 2014

Optimal Duration of DAPT After Intracoronary Stenting: Current Status

Presenter: Roxana Mehran

September 13, 2014

Presentation

Issues with DAPT: An Expert Case-Based Discussion

Presenter: Jonathan Halperin, Ajay Kirtane, Roxana Mehran

July 29, 2014

Presentation Physiology and Intravascular Imaging 2014

Utility of IVUS and OCT to Improve Clinical Outcomes - Update on Recent Study Data and Meta-analyses

Presenter: Roxana Mehran

March 27, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation TCT 2013

Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

DES Implantation in a Patient with Atrial Fibrillation

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

Trading off Ischemic vs. Hemorrhagic Complications of PCI: Implications for Drug and Vascular Access Decision-Making

Presenter: Roxana Mehran

October 30, 2013

Presentation TCT 2013

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Presenter: Roxana Mehran

October 30, 2013

Presentation TCT 2013

Introduction

Presenter: Roxana Mehran

October 30, 2013

Presentation

Case 4: Patient with Atrial Fibrillation and DES

Presenter: Roxana Mehran

October 29, 2013

Presentation TCT 2013

Critical Appraisal and Clinical Implications

Presenter: Roxana Mehran

October 29, 2013

Presentation TCT 2013

Current Choice of Antiplatelet Therapies in NSTEMI and STEMI

Presenter: Roxana Mehran

October 28, 2013

Presentation TCT 2013

Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter?

Presenter: Roxana Mehran

October 28, 2013

Presentation TCT 2013

Current Drugs and Devices for Primary PCI

Presenter: Roxana Mehran

October 28, 2013

Presentation TCT 2013

Welcome/ Introductions/ Session Objectives

Presenter: Roxana Mehran

October 27, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

Presentation SOLACI 2013

Dealing with In-Stent Restenosis: Mechanisms, Predictors, and Clinical Implications

Presenter: Roxana Mehran

July 25, 2013

Presentation SOLACI 2013

DES in Perspective: What is New?

Presenter: Roxana Mehran

July 25, 2013

Advertisement

Setting-up a Thriving Clinical Research Program: The Basics and More

Optimal Duration of DAPT After Intracoronary Stenting: Current Status

Issues with DAPT: An Expert Case-Based Discussion

Utility of IVUS and OCT to Improve Clinical Outcomes - Update on Recent Study Data and Meta-analyses

Left Main Restenosis: Incidence, Implications, and Management

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies

DES Implantation in a Patient with Atrial Fibrillation

Trading off Ischemic vs. Hemorrhagic Complications of PCI: Implications for Drug and Vascular Access Decision-Making

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Introduction

Case 4: Patient with Atrial Fibrillation and DES

Critical Appraisal and Clinical Implications

Current Choice of Antiplatelet Therapies in NSTEMI and STEMI

Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter?

Current Drugs and Devices for Primary PCI

Welcome/ Introductions/ Session Objectives

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Dealing with In-Stent Restenosis: Mechanisms, Predictors, and Clinical Implications

DES in Perspective: What is New?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content